Literature DB >> 22210439

In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum.

Lucienne Tritten1, Uzoma Nwosu, Mireille Vargas, Jennifer Keiser.   

Abstract

Worldwide, 3 billion people are at risk of hookworm infection, particularly in resource-poor countries. While control of soil-transmitted helminthiases relies mostly on chemotherapy, only few drugs are available and concern about potential emergence of drug resistance is rising. In the present study, tribendimidine, a derivative of amidantel, and its metabolites deacylated amidantel (dADT) and acetylated deacylated amidantel (AdADT) were tested in vitro and in vivo against Heligmosomoides bakeri and Ancylostoma ceylanicum, two hookworm rodent models, alone or in combination with standard drugs. Tribendimidine achieved IC(50)s ≤ 5 μg/ml against both H. bakeri third-stage larvae and adults in vitro and a single 2 mg/kg oral dose resulted in complete worm elimination in vivo. Comparable results were obtained with dADT, whereas AdADT displayed no effect in vitro and gave a moderate worm burden reduction of 42.9% in H. bakeri-infected mice. Tribendimidine combined with albendazole, levamisole or ivermectin revealed antagonistic interactions against H. bakeri in vitro and no significant killing effect in vivo. Tribendimidine and dADT exerted high efficacies against A. ceylanicum third-stage larvae (IC(50)s < 0.5 μg/ml) whereas adults were moderately affected in vitro (IC(50)s > 88 μg/ml). In vivo at single oral doses of 10 mg/kg, dADT showed a slightly higher efficacy than tribendimidine, achieving worm burden reductions of 87.4% and 74.8%, respectively. At the same dose, AdADT reduced the worm burden by 57.9%. Synergistic interactions were observed with tribendimidine-levamisole combinations against A. ceylanicum in vitro (combination index at IC(50)=0.5), and in vivo (combination index at ED(90)=0.19). In conclusion, tribendimidine and dADT show potent anti-hookworm properties. The potential of the promising tribendimidine-levamisole combination should be investigated in greater detail.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210439     DOI: 10.1016/j.actatropica.2011.12.008

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  16 in total

1.  In vitro efficacy of cyclooctadepsipepdtides and aminophenylamidines alone and in combination against third-stage larvae and adult worms of Nippostrongylus brasiliensis and first-stage larvae of Trichinella spiralis.

Authors:  Daniel Kulke; Jürgen Krücken; Janina Demeler; Achim Harder; Heinz Mehlhorn; Georg von Samson-Himmelstjerna
Journal:  Parasitol Res       Date:  2012-10-02       Impact factor: 2.289

2.  In vivo anthelmintic activity of Carex baccans and its active principle resveratrol against Hymenolepis diminuta.

Authors:  Bikash Ranjan Giri; Ravi Rao Bharti; Bishnupada Roy
Journal:  Parasitol Res       Date:  2015-01-14       Impact factor: 2.289

3.  Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases.

Authors:  Yan Hu; Melanie M Miller; Alan I Derman; Brian L Ellis; Rose Gomes Monnerat; Joe Pogliano; Raffi V Aroian
Journal:  Appl Environ Microbiol       Date:  2013-07-08       Impact factor: 4.792

4.  Population Pharmacokinetics and Exposure-Response Analysis of Tribendimidine To Improve Treatment for Children with Hookworm Infection.

Authors:  Marc Pfister; Jennifer Keiser; Janneke M Brussee; Noemi Hiroshige; Anna Neodo; Jean T Coulibaly
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

5.  Pharmacometric Analysis of Tribendimidine Monotherapy and Combination Therapies To Achieve High Cure Rates in Patients with Hookworm Infections.

Authors:  Janneke M Brussee; Anna Neodo; Jessica D Schulz; Jean T Coulibaly; Marc Pfister; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

6.  In Vitro and In Vivo Drug-Drug Interaction Study of the Effects of Ivermectin and Oxantel Pamoate on Tribendimidine.

Authors:  Anna Neodo; Jessica D Schulz; Jörg Huwyler; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

7.  In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility.

Authors:  Rebecca S Treger; Joseph Otchere; Martin F Keil; Josephine E Quagraine; Ganesha Rai; Bryan T Mott; Debbie L Humphries; Michael Wilson; Michael Cappello; Jon J Vermeire
Journal:  Am J Trop Med Hyg       Date:  2013-12-02       Impact factor: 2.345

8.  Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination.

Authors:  Lucienne Tritten; Angelika Silbereisen; Jennifer Keiser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-03-10       Impact factor: 4.077

9.  Pharmacokinetics of a Pediatric Tribendimidine Dose-Finding Study To Treat Hookworm Infection in African Children.

Authors:  Noemi Hiroshige; Jean Coulibaly; Jörg Huwyler; Peter L Bonate; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

10.  Activity of oxantel pamoate monotherapy and combination chemotherapy against Trichuris muris and hookworms: revival of an old drug.

Authors:  Jennifer Keiser; Lucienne Tritten; Angelika Silbereisen; Benjamin Speich; Roberto Adelfio; Mireille Vargas
Journal:  PLoS Negl Trop Dis       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.